Study evaluated the changes in the transmission of EV-D68 in England inferred from seroprevalence data.
EMA looks to make its drug approval processes more efficient
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS